Tema Obesity & Cardiometabolic ETF (HRTS) Chart & Stock Price History $29.71 +0.22 (+0.75%) As of 03:08 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHoldingsRatings Tema Obesity & Cardiometabolic ETF Stock Price Performance 5 Day Performance-1.88%1 Month Performance-1.46%3 Month Performance-2.94%6 Month Performance-13.38%Year-To-Date Performance+2.91%1 Year Performance-12.05% Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Remove Ads HRTS Stock Chart for Wednesday, March, 12, 2025 HRTS Chart by TradingViewRemove Ads Tema Obesity & Cardiometabolic ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/12/2025$29.49$29.71+0.75%$29.76$29.472,522 shs$62.39 million03/11/2025$29.53$29.49-0.14%$29.59$29.176,287 shs$61.93 million03/10/2025$30.28$29.53-2.48%$29.95$29.5011,709 shs$62.01 million03/07/2025$30.51$30.28-0.75%$30.50$30.233,036 shs$63.59 million03/06/2025$30.81$30.51-0.97%$30.65$30.356,061 shs$57.66 million03/05/2025$30.41$30.81+1.32%$30.85$30.4113,153 shs$58.23 million03/04/2025$30.58$30.41-0.56%$30.42$30.1871,578 shs$57.48 million03/03/2025$30.78$30.58-0.65%$30.92$30.524,172 shs$57.80 million02/28/2025$30.44$30.78+1.12%$30.78$30.3515,828 shs$58.17 million02/27/2025$30.53$30.44-0.29%$30.73$30.444,521 shs$57.53 million Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. 02/26/2025$30.60$30.53-0.23%$30.76$30.536,700 shs$57.70 million02/25/2025$30.66$30.60-0.20%$30.73$30.3713,038 shs$57.83 million02/24/2025$30.72$30.66-0.20%$30.90$30.64159,875 shs$57.95 million02/21/2025$30.74$30.72-0.07%$30.95$30.664,589 shs$58.06 million02/20/2025$30.55$30.74+0.62%$30.74$30.504,878 shs$58.10 million02/19/2025$30.20$30.55+1.16%$30.55$30.139,450 shs$57.74 million02/18/2025$30.08$30.20+0.40%$30.30$30.085,747 shs$57.08 million02/17/2025$30.08$30.08$30.25$30.084,221 shs$56.85 million02/14/2025$30.05$30.08+0.10%$30.25$30.084,221 shs$56.85 million02/13/2025$30.15$30.05-0.33%$30.16$30.056,638 shs$56.79 million02/12/2025$29.94$30.15+0.70%$30.15$29.645,045 shs$56.98 million02/11/2025$30.12$29.94-0.60%$30.08$29.896,968 shs$56.59 million Related Companies Themes Lithium & Battery Metal Miners ETF Stock Price Chart Themes Copper Miners ETF Stock Price Chart Stone Ridge 2060 Inflation Protected Longevity Income ETF Stock Price Chart X-Square Balanced Fund, LLC A Stock Price Chart Stone Ridge 2059 Inflation-Protected Longevity Income ETF Stock Price Chart Ocean Park International ETF Stock Price Chart Themes Robotics & Automation ETF Stock Price Chart Themes Uranium & Nuclear ETF Stock Price Chart ARK 21Shares Active Ethereum Futures Strategy ETF Stock Price Chart Stone Ridge 2061 Inflation Protected Longevity Income ETF Stock Price Chart Receive HRTS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:HRTS) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
